Novo Nordisk ousts boss as Ozempic maker battles slump
[ad_1] Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Novo Nordisk has ousted
Novo Nordisk cuts sales forecasts on lower US demand for obesity drug
[ad_1] Stay informed with free updates Simply sign up to the Pharmaceuticals sector myFT Digest — delivered directly to your inbox. Danish drugmaker Novo Nordisk
Novo Nordisk foundation’s obesity head works as paid adviser to chocolate maker Ferrero
[ad_1] Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The head of the
